Latest Options News

Falcon Metals reports steady progress across its Victorian and Western Australian projects, maintaining a strong cash position to fuel ongoing exploration in 2025.

InhaleRx has locked in a $38.5 million funding deal with Clendon Biotech Capital, enabling expanded Phase 2 trials for its inhaled breakthrough cancer pain and panic disorder treatments. The company also filed a key international patent, positioning itself for a faster path to FDA approval.

Javelin Minerals has completed Phase 1 drilling at its Coogee Gold Project with assay results pending, while finalizing the acquisition of the Eureka Gold Project and preparing for further drilling in early 2025.

Investigator Resources Limited has postponed the Definitive Feasibility Study (DFS) for its Paris Silver Project to mid-2025, citing rising costs and the need for further optimisation. Meanwhile, exploration drilling continues and asset sales bolster the company’s cash position to $2.7 million.

Prospech Limited has reported a significant milestone with a JORC-compliant Inferred Mineral Resource Estimate of 7.1 million tonnes at 1.08% TREO for its Korsnäs REE project in Finland, alongside successful EU grant funding and a rights issue raising nearly $786,000.

Santana Minerals has reported a robust Pre-feasibility Study for its Bendigo-Ophir Gold Project, lifting the after-tax NPV to A$1.2 billion and IRR to 76%, as it progresses detailed engineering and fast-track permitting in New Zealand.

Mithril Silver and Gold Limited reports compelling high-grade silver and gold intercepts from its ongoing Target 1 drilling campaign in Mexico’s Copalquin District, setting the stage for a resource update and expanded exploration in 2025.

Horizon Gold advances its Gum Creek Gold Project with ongoing diamond drilling and a major upcoming RC drilling campaign aimed at upgrading its 2.14 million ounce gold resource. The company also strengthens its balance sheet following a strategic share sale.

Condor Energy Ltd has raised A$3 million through a well-supported placement to advance its exploration and commercialisation efforts in the Tumbes Basin offshore Peru, focusing on the promising Piedra Redonda gas discovery.

Rhythm Biosciences reported a strong December quarter, securing a $3.2 million R&D tax incentive and completing a strategic acquisition of Genetype assets, positioning the company for commercial expansion in cancer diagnostics.

Felix Gold Limited reports outstanding trenching results at its Treasure Creek Project in Alaska, revealing high-grade antimony and gold mineralization that bolsters prospects for near-term production amid critical U.S. supply chain needs.

Regal Investment Fund has updated its dividend announcement, confirming an actual ordinary dividend of AUD 0.10 per unit payable in March 2025. The distribution relates to the six-month period ending December 31, 2024.